Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 9—September 2024
Research

Medical Costs of Nontuberculous Mycobacterial Pulmonary Disease, South Korea, 2015–2019

Shihwan Chang1, Sol Kim1, Young Ae Kang, Moo Suk Park, Hojoon Sohn2, and Youngmok Park2Comments to Author 
Author affiliations: Yonsei University College of Medicine, Seoul, South Korea (S. Chang, S. Kim, Y.A. Kang, M.S. Park, Y. Park); Severance Hospital, Seoul (S. Chang, S. Kim, Y.A. Kang, M.S. Park, Y. Park); Seoul National University College of Medicine, Seoul (H. Sohn); Seoul National University Institute of Health Policy and Management, Seoul (H. Sohn)

Main Article

Table 1

Definitions of visits related to NTM-PD and assessment costs based on category and relevance of treatment used in study of medical costs of NTM-PD, South Korea, 2015–2019*

Variable
Examples
Category
Medications All medications, all fees for drug administration (i.e., intravenous access) and dispensing
Diagnostic tests Acid fast bacilli smear/cultures, NTM identification, NTM drug-susceptibility tests, laboratory tests using patient specimen (i.e., complete blood count, blood chemistry, urinalysis), imaging studies (e.g., computed tomography, radiography), pulmonary function tests, induced sputum, invasive procedures (e.g., bronchoscopy, radiologic intervention)
Clinical services Doctors’ fees for admission, outpatient visits, and consultation; hospital fees; meals during admission; fees for documentation

*NTM-PD-related visits were defined as all visits to the pulmonology department and nonpulmonology visits, including outpatient referrals for management of adverse events during NTM-PD treatment, consultations during admissions for NTM-PD management, and visits for surgical management of NTM-PD. Non-NTM-PD–related visits defined as all nonpulmonology visits that do not fit the criteria for an NTM-PD-related visit (i.e., visits for hypertension). NTM, nontuberculous mycobacteria; PD, pulmonary disease.

Main Article

1These first authors contributed equally to this article.

2These authors were co–principal investigators.

Page created: July 30, 2024
Page updated: August 22, 2024
Page reviewed: August 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external